Texas Yale Capital Corp. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 5.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,206 shares of the medical equipment provider’s stock after acquiring an additional 255 shares during the quarter. Texas Yale Capital Corp.’s holdings in Intuitive Surgical were worth $2,829,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. TD Capital Management LLC boosted its position in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the period. 1248 Management LLC purchased a new stake in Intuitive Surgical in the 1st quarter worth about $30,000. Princeton Global Asset Management LLC acquired a new stake in Intuitive Surgical during the 2nd quarter worth about $30,000. Bank of Jackson Hole Trust grew its stake in Intuitive Surgical by 70.5% during the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 31 shares in the last quarter. Finally, CBIZ Investment Advisory Services LLC increased its holdings in shares of Intuitive Surgical by 49.1% in the 1st quarter. CBIZ Investment Advisory Services LLC now owns 82 shares of the medical equipment provider’s stock valued at $41,000 after purchasing an additional 27 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.
Insiders Place Their Bets
In related news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Craig H. Barratt sold 2,193 shares of the company’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $548.01, for a total transaction of $1,201,785.93. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 98,078 shares of company stock worth $51,445,892 in the last ninety days. 0.70% of the stock is owned by insiders.
Analyst Ratings Changes
Get Our Latest Stock Analysis on ISRG
Intuitive Surgical Stock Performance
Shares of NASDAQ ISRG opened at $547.78 on Friday. The firm has a market cap of $196.37 billion, a price-to-earnings ratio of 72.46, a P/E/G ratio of 4.94 and a beta of 1.62. The business’s 50-day simple moving average is $470.16 and its 200-day simple moving average is $500.23. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period in the previous year, the company earned $1.84 EPS. The company’s revenue for the quarter was up 22.9% on a year-over-year basis. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- What is an Earnings Surprise?
- DigitalOcean’s Tide Has Turned: Get Ready to Ride the Wave
- P/E Ratio Calculation: How to Assess Stocks
- CAVA Stock Looking for Direction After Earnings Miss
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Small AI Stocks Ready to Explode (All Under $20)
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
